Scoggin Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Scoggin Management’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-2,000,000	Closed	-$1M	–	120
2014 Q2	$1M	Hold	2,000,000	–	–	0.06%	81
2014 Q1	$620K	Buy	+2,000,000	New	+$743K	0.06%	80

Other funds holding GCVRZ

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return

Allianz Asset Management

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Scoggin Management's GCVRZ Position: Q3 2014 in Review

Scoggin Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q3 2014, closing a stake of 2,000,000 shares — an estimated $1M sold.

Scoggin Management first reported a position in GCVRZ in Q1 2014 and held it in 2 quarters. The position peaked at $1M in Q2 2014. 118 funds tracked by Wall St. Rank hold GCVRZ as of Q3 2014.

Scoggin Management reported no remaining Sanofi Contingent Value Rights position as of Q3 2014 after selling out during the quarter.
Scoggin Management sold 2,000,000 Sanofi Contingent Value Rights shares in Q3 2014, an estimated $1M.
Scoggin Management first reported a position in Sanofi Contingent Value Rights in Q1 2014 and held it in 2 quarters.
Scoggin Management's Sanofi Contingent Value Rights position peaked at $1M in Q2 2014.
118 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q3 2014.

Based on Scoggin Management's 13F filing for Q3 2014, filed 14 Nov 2014.